Patents by Inventor Peter Chater

Peter Chater has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250282839
    Abstract: The present invention relates to a purified, biocompatible mucus, which has the ability to form a gel. The mucus of the invention may be provided in a tissue model, with a cell population. The mucin or tissue model of the invention may be useful in an in vitro model of digestion, mucus permeation and/or epithelial transport.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 11, 2025
    Applicant: Aelius Biotech Limited
    Inventors: Peter Chater, Matthew Wilcox, Kyle Stanforth, Maria Zakhour, Jeffrey Pearson
  • Patent number: 10191062
    Abstract: The invention relates to a Model Gut System (MGS) comprising a pancreatic phase consisting essentially of synthetic pancreatic juice comprising pancreatin and one or more suitable pancreatic diluent(s) at a pH from about 7 to about 9, preferably about 7.9 to about 8.2, and porcine bile.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: January 29, 2019
    Assignee: University of Newcastle Upon Tyne
    Inventors: Jeff Pearson, Iain Brownlee, Matt Wilcox, Peter Chater, David Houghton
  • Publication number: 20180067122
    Abstract: The invention relates to a Model Gut System (MGS) comprising a pancreatic phase consisting essentially of synthetic pancreatic juice comprising pancreatin and one or more suitable pancreatic diluent(s) at a pH from about 7 to about 9, preferably about 7.9 to about 8.2, and porcine bile.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 8, 2018
    Applicant: University of Newcastle Upon Tyne
    Inventors: Jeff Pearson, Iain Brownlee, Matt Wilcox, Peter Chater
  • Publication number: 20170160283
    Abstract: The invention relates to a Model Gut System (MGS) comprising a pancreatic phase consisting essentially of synthetic pancreatic juice comprising pancreatin and one or more suitable pancreatic diluent(s) at a pH from about 7 to about 9, preferably about 7.9 to about 8.2, and porcine bile.
    Type: Application
    Filed: November 21, 2014
    Publication date: June 8, 2017
    Inventors: Jeff Pearson, Iain Brownlee, Matt Wilcox, Peter Chater